Synthesis and anti-inflammatory activity evaluation of novel 7-alkoxy-1-amino-4,5-dihydro[1,2,4]triazole[4,3-a]quinolines

Archiv der Pharmazie

Volumn 341, Issue 5, 2008, Pages 288-293

  Sun, Xian Yu ^a   Wei, Cheng Xi ^a   Chai, Kyu Yun ^b   Piao, Hu Ri ^a   Quan, Zhe Shan ^a  

^a YANBIAN UNIVERSITY   (China)

^b Wonkwang University   (South Korea)

Author keywords

1,2,4 Triazole; Anti inflammatory; Quinoline

Indexed keywords

7 (2 CHLOROBENZYLOXY) 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 (2 FLUOROBENZYLOXY) 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 (2,4 DICHLOROBENZYLOXY) 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 (3 CHLOROBENZYLOXY) 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 (3 FLUOROBENZYLOXY) 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 (4 BROMINEBENZYLOXY) 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 (4 CHLOROBENZYLOXY) 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 (4 FLUOROBENZYLOXY) 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 (4 METHYLBENZYLOXY) 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 ALKOXY 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 BENZYLOXY 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 BUTYLOXY 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 DODECYLOXY 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 HEXYLOXY 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 OCTYLOXY 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; 7 PROPYLOXY 1 AMINO 4,5 DIHYDRO[1,2,4]TRIAZOLE[4,3 A]QUINOLINE; ANTIINFLAMMATORY AGENT; IBUPROFEN; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; XYLENE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; EDEMA; MOUSE; NONHUMAN; OTITIS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; ANIMAL; SYNTHESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; MICE; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 46449106774     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700182     Document Type: Article

References (19)

1. J. R. Van, R. M. Botting, Inflamm. Res. 1995, 44, 1-10.
2. B. Tozkoparan, E. Kupeli, E. Yesilada, M. Ertan, Bioorg. Med. Chem. 2007, 15, 1808-1814.
3. O. A. Al-Deeb, M. A. Al-Omar, N. R. El-Brollosy, E. E. Habib, et al., Arzneimittelforschung 2006, 56, 40-47.
4. L. Navidpour, H. Shafaroodi, K. Abdi, M. Amini, et al., Bioorg. Med. Chem. 2006, 14, 2507-2514.
5. B. Tozkoparan, E. Kupeli, E. Yesilada, S. Isik, et al., Arzneimittelforschung 2005, 55, 533-540.
6. M. Amir, S. Kumar, Arch. Pharm. (Weinheim) 2005, 338, 24-31.
7. L. Labanauskas, E. Udrenaite, P. Gaidelis, A. Brukstus, Farmaco 2004, 59, 255-259.
8. B. Tozkoparan, G. Aktay, E. Yesilada, Farmaco 2002, 57, 145-152.
9. E. Palaska, G. Sahin, P. Kelicen, N. T. Durlu, G. Altinok, Farmaco 2002, 57, 101-107.
10. B. Berk, G. Aktay, E. Yesilada, M. Ertan, Pharmazie 2001, 56, 613-616.
11. L. Labanauskas, V. Kalcas, E. Udrenaite, P. Gaidelis, et al., Pharmazie 2001, 56, 617-619.
12. G. Sahin, E. Palaska, P. Kelicen, R. Demirdamar, G. Altinok, Arzneimittelforschung 2001, 51, 478-484.
13. Z.-F. Xie, K.-Y. Chai, H. R. Piao, K. C. Kwak, Z. S. Quan, Bioorg. Med. Chem. Lett 2005, 15, 4803-4805.
14. H. G. Jin, X. Y. Sun, K. Y. Chai, H. R. Piao, Z. S. Quan, Bioorg. Med. Chem. 2006, 14, 6868-6873.
15. L. J. Cui, Z. F. Xie, H. R. Piao, K. Y. Chai, Z. S. Quan, Biol. Pharm. Bull. 2005, 28, 1216-1220.
16. Z. S. Quan, J. M. Wang, J. R. Rho, K. C. Kwak, et al., Bull. Korean Chem. Soc. 2005, 26, 1757-1760.
17. X.-Y. Sun, Y.-Z. Jin, L. Fu-Nan, L. Gao, et al., Arch. Pharm. Res. 2006, 29, 1080-1085.
18. T. Ramalingam, M. S. Murty, Y. V. D. Nageswar, P. B. Sattur, J. Heterocyclic. Chem. 1990, 27, 981-982.
19. G. Chen, W. Shan, Y. Wa, L. Ren, et al., Chem. Pharm. Bull. 2005, 53, 1587-1590.